|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 52.23 USD | -1.53% |
|
52.66 | +0.81% |
| Market Cap | 78.16B 105B 90.53B 83.32B 147B 9,927B 148B 985B 385B 4,861B 394B 386B 16,821B | P/E Ratio 2026 * |
12.6x | P/E Ratio 2027 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 92.41B 124B 107B 98.51B 174B 11,737B 175B 1,165B 455B 5,748B 466B 456B 19,888B | EV / Sales 2026 * |
2.74x | EV / Sales 2027 * | 2.52x |
| Free-Float |
92.3% | Yield 2026 * |
3.58% | Yield 2027 * | 3.74% |
Last Transcript: GSK plc
| 1 day | -1.53% | ||
| 1 week | +3.14% | ||
| Current month | +3.34% | ||
| 1 month | +5.15% | ||
| 3 months | -2.17% | ||
| 6 months | +6.07% | ||
| Current year | +6.50% |
| 1 week | 50.98 |  | 53.45 |
| 1 month | 48.57 | | 53.45 |
| Current year | 47.62 | | 61.7 |
| 1 year | 35.45 | | 61.7 |
| 3 years | 31.72 | | 61.7 |
| 5 years | 28.46 | | 61.7 |
| 10 years | 28.46 | | 61.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
| Chief Tech/Sci/R&D Officer | - | 2021-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 68 | 2019-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.53% | +3.14% | - | - | 106B | |
| -0.32% | -1.72% | +37.83% | +148.79% | 1,010B | |
| -2.16% | +1.51% | +50.01% | +43.93% | 580B | |
| -2.70% | -0.66% | +15.97% | +63.07% | 402B | |
| -1.18% | +1.05% | +20.91% | +18.37% | 330B | |
| -1.52% | +2.45% | +23.73% | +33.03% | 281B | |
| -1.95% | -4.32% | +20.15% | +12.96% | 280B | |
| -0.57% | +5.00% | -44.67% | -48.28% | 197B | |
| -1.31% | +1.39% | +18.74% | +53.45% | 192B | |
| -0.38% | -2.97% | +13.02% | +57.34% | 156B | |
| Average | -1.27% | +0.02% | +17.30% | +42.52% | 380.97B | |
| Weighted average by Cap. | -1.04% | -0.16% | +26.16% | +67.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.78B 45.4B 39.13B 36.01B 63.46B 4,291B 64.09B 426B 166B 2,101B 170B 167B 7,271B | 35.48B 47.67B 41.09B 37.82B 66.64B 4,506B 67.31B 447B 175B 2,206B 179B 175B 7,635B |
| Net income | 6.27B 8.42B 7.26B 6.68B 11.77B 796B 11.89B 78.97B 30.85B 390B 31.6B 30.93B 1,349B | 6.67B 8.96B 7.72B 7.11B 12.53B 847B 12.65B 84.04B 32.83B 415B 33.63B 32.92B 1,435B |
| Net Debt | 14.25B 19.15B 16.51B 15.19B 26.77B 1,810B 27.04B 180B 70.16B 886B 71.87B 70.35B 3,067B | 11.19B 15.04B 12.96B 11.93B 21.02B 1,421B 21.23B 141B 55.08B 696B 56.43B 55.23B 2,408B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-15 | 52.23 $ | -1.53% | 3,434,088 |
| 26-06-12 | 53.04 $ | +0.34% | 3,805,968 |
| 26-06-11 | 52.86 $ | +3.30% | 5,018,503 |
| 26-06-10 | 51.17 $ | -0.16% | 5,076,049 |
| 26-06-09 | 51.25 $ | +1.20% | 6,115,445 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
